Phase I results will be presented at the International Conference on Mucosal Vaccines, Adjuvants & Delivery, in Copenhagen
Tid 25 September 2013 – 27 September 2013
Plats Copenhagen
In September results of the clinical Phase I study of our novel vaccine against diarrhea caused by ETEC will be presented at the International Conference on Mucosal Vaccines, Adjuvants & Delivery, in Copenhagen. The three day conference (25-27 September) key focus will be on the requirements and the importance of mucosal vaccines and adjuvants in the treatment of serious disorders.